| Title: | Telomere length and brain imaging phenotypes in UK Biobank |
| Journal: | PLOS ONE |
| Published: | 22 Mar 2023 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/36947528/ |
| DOI: | https://doi.org/10.1371/journal.pone.0282363 |
| URL: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0282363&type=printable |
Publication 7896
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Telomeres form protective caps at the ends of chromosomes, and their attrition is a marker of biological aging. Short telomeres are associated with an increased risk of neurological and psychiatric disorders including dementia. The mechanism underlying this risk is unclear, and may involve brain structure and function. However, the relationship between telomere length and neuroimaging markers is poorly characterized. Here we show that leucocyte telomere length (LTL) is associated with multi-modal MRI phenotypes in 31,661 UK Biobank participants. Longer LTL is associated with: i) larger global and subcortical grey matter volumes including the hippocampus, ii) lower T1-weighted grey-white tissue contrast in sensory cortices, iii) white-matter microstructure measures in corpus callosum and association fibres, iv) lower volume of white matter hyperintensities, and v) lower basal ganglia iron. Longer LTL was protective against certain related clinical manifestations, namely all-cause dementia (HR 0.93, 95% CI: 0.91-0.96), but not stroke or Parkinson's disease. LTL is associated with multiple MRI endophenotypes of neurodegenerative disease, suggesting a pathway by which longer LTL may confer protective against dementia.12 Authors
- Anya Topiwala
- Thomas E. Nichols
- Logan Z. J. Williams
- Emma C. Robinson
- Fidel Alfaro-Almagro
- Bernd Taschler
- Chaoyue Wang
- Christopher P. Nelson
- Karla L. Miller
- Veryan Codd
- Nilesh J. Samani
- Stephen M. Smith
Enabling scientific discoveries that improve human health